Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,657 | 5 | 84.9% |
| Food and Beverage | $279.97 | 3 | 14.3% |
| Education | $15.76 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,278 | 4 | $0 (2019) |
| CSL Behring | $659.11 | 4 | $0 (2024) |
| Chiesi USA, Inc. | $15.76 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $659.11 | 4 | CSL Behring ($659.11) |
| 2023 | $15.76 | 1 | Chiesi USA, Inc. ($15.76) |
| 2019 | $1,278 | 4 | Novartis Pharmaceuticals Corporation ($1,278) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $295.26 | General |
| 12/06/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $85.00 | General |
| 12/06/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 12/05/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $218.85 | General |
| 08/22/2023 | Chiesi USA, Inc. | FERRIPROX (Drug) | Education | Cash or cash equivalent | $15.76 | General |
| Category: TREAT IRON OVERLOAD FROM THALASSEMIA, SICKLE CELL OR ANOTHER ANEMIA | ||||||
| 07/19/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | Cash or cash equivalent | $518.77 | General |
| Category: HEMATOLOGY | ||||||
| 07/19/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | In-kind items and services | $297.39 | General |
| Category: HEMATOLOGY | ||||||
| 07/19/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $134.97 | General |
| Category: HEMATOLOGY | ||||||
| 07/18/2019 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $327.00 | General |
About Dr. Robert Liem, MD
Dr. Robert Liem, MD is a Pediatric Hematology-Oncology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548238926.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Liem, MD has received a total of $1,953 in payments from pharmaceutical and medical device companies, with $659.11 received in 2024. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Travel and Lodging" ($1,657).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Chicago, IL
- Active Since 03/10/2006
- Last Updated 08/29/2025
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1548238926
Products in Payments
- ADAKVEO (Biological) $951.13
- FERRIPROX (Drug) $15.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Chicago
Alexis Thompson, Md, MD
Pediatric Hematology-Oncology — Payments: $1.6M
James Labelle
Pediatric Hematology-Oncology — Payments: $249,251
Sherif Badawy, Md, MD
Pediatric Hematology-Oncology — Payments: $207,866
Dr. Loretta Li, M.d, M.D
Pediatric Hematology-Oncology — Payments: $187,559
Susan Cohn
Pediatric Hematology-Oncology — Payments: $125,685
Leonard Valentino, M.d, M.D
Pediatric Hematology-Oncology — Payments: $117,453